The ability of cells to internalize nanoparticles through pinocytosis presents a promising avenue for the targeted delivery of drugs, genes, and other therapeutic agents. By designing nanoparticles that can be selectively internalized, researchers can improve the efficacy and reduce the side effects of treatments. This is particularly relevant in cancer therapy, where targeted delivery can improve the therapeutic index of anticancer drugs.
